News & Updates

Treatment with the anti-interleukin (IL)-12/-23 monoclonal antibody ustekinumab yields a high rate of clinical remission in patients with moderate-to-severe Crohn’s disease (CD) in the real-world setting, according to a study presented at AIBD 2021.

For patients undergoing direct acting antiviral (DAA) therapy for hepatitis C virus (HCV)/hepatitis B virus (HBV) dual infection, cotreatment with entecavir helps avert reactivation of HBV, as shown in a study.

Patients with inflammatory bowel disease (IBD) who consume probiotics can develop brain fog, especially men and those who are Caucasian, as suggested in a study.

Percutaneous endoscopic gastrostomy (PEG) leads to fewer adverse outcomes and lower 30-day mortality than interventional radiologist-guided gastrostomy (IRG), according to a study.

Assisted reproductive technology (ART) is both safe and effective in women with ulcerative colitis and medically managed Crohn’s disease (CD), with comparable pregnancy and live birth rates to those of the general population, a study has shown.

Late anastomotic leakage (AL) is more common than AL in rectal cancer patients who undergo surgery after neoadjuvant chemoradiotherapy (nCRT) and is less likely to involve require intensive intervention, a recent study has found.

Increased serum iron or transferrin saturation levels in individuals with non-alcoholic fatty liver disease (NAFLD) may point to an increased risk of hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting Digital Experience™.

Switching to tenofovir alafenamide (TAF) from nucleos(t)ide analogue therapies was associated with improved virologic response and liver function in patients with chronic hepatitis B virus (HBV) infection, even in those with decompensated HBV cirrhosis, according to real-world studies presented at AASLD 2021.